MEDX.SW SIX
medmix AG
1W: -2.5%
1M: +10.0%
3M: +21.4%
YTD: -17.3%
1Y: -9.9%
3Y: -56.1%
CHF 9.89 ($11.94)
+0.06 (+0.61%)
Weekly Expected Move ±4.8%
CHF 9
CHF 9
CHF 10
CHF 10
CHF 11
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$448M
-7.4% ▼
5Y CAGR: +5.0%
Gross Profit
$162M
+1.4% ▲
5Y CAGR: +6.0%
Operating Income
$27M
+112.4% ▲
5Y CAGR: +8.6%
Net Income
$6M
+186.5% ▲
5Y CAGR: -7.8%
EPS (Diluted)
$0.15
+183.3% ▲
5Y CAGR: -8.2%
EBITDA
$80M
+17.9% ▲
5Y CAGR: +5.5%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $457M | $477M | $487M | $484M | $448M |
| YoY Growth | +30.2% | +4.3% | +2.0% | -0.6% | -7.4% |
| Cost of Revenue | $276M | $302M | $329M | $324M | $286M |
| Gross Profit | $181M | $175M | $158M | $160M | $162M |
| Gross Margin | 39.6% | 36.8% | 32.4% | 33.0% | 36.1% |
| R&D Expenses | $23M | $24M | $26M | $25M | $20M |
| SG&A Expenses | $96M | $103M | $119M | $116M | $115M |
| Operating Expenses | $121M | $156M | $142M | $147M | $134M |
| Operating Income | $60M | $20M | $16M | $13M | $27M |
| Operating Margin | 13.1% | 4.1% | 3.3% | 2.7% | 6.1% |
| Interest Expense | $8M | $6M | $10M | $12M | $9M |
| Income Before Tax | $51M | $12M | $3M | -$6M | $9M |
| Tax Expense | $7M | $600K | $2M | $0 | $2M |
| Net Income | $44M | $12M | $300K | -$7M | $6M |
| Net Margin | 9.6% | 2.4% | 0.1% | -1.5% | 1.4% |
| EPS (Diluted) | $1.07 | $0.28 | $0.01 | $-0.18 | $0.15 |
| EBITDA | $111M | $68M | $68M | $68M | $80M |
| Shares Outstanding | 41M | 41M | 41M | 41M | 42M |